Pfizer Inc., New York, New York, was awarded a $5,295,000,000 firm-fixed-price contract for 10 million doses of Pfizer’s oral protease inhibitor drug PF-07321332. Bids were solicited via the internet with 10 received. Work will be performed in New York, New York, with an estimated completion date of March 31, 2023. Fiscal 2021 CARES Act and Paycheck Protection Program and Health Care Enhancement Act funds in the amount of $5,295,000,000 were obligated at the time of the award. U.S. Army Contracting Command, Aberdeen Proving Ground, Maryland, is the contracting activity (W58P05-22-C-0001). (Awarded Nov. 17, 2021)